# The Effect of Antibiotic Eye Drops on the Nasal Microbiome in Healthy Subjects

> **NCT05287425** · PHASE2 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 20 (actual)

## Conditions studied

- Nasal and Pharyngeal Microbiome

## Interventions

- **DRUG:** Gentamicin Ophthalmic
- **DRUG:** Ciprofloxacin Ophthalmic
- **DRUG:** Povidone Ophthalmic
- **DRUG:** Povidone and Benzalkonium Chloride Ophthalmic

## Key facts

- **NCT ID:** NCT05287425
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-12
- **Primary completion:** 2023-08-28
- **Final completion:** 2023-08-28
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05287425

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05287425, "The Effect of Antibiotic Eye Drops on the Nasal Microbiome in Healthy Subjects". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05287425. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*